Harnessing Characterization & Analytical Methods to Illuminate LNP Structure & Enable Stability, Integrity, & Efficacy for Regulatory Submissions & Next Generation Constructs
As LNP systems become more sophisticated and RNA therapeutics move toward targeted delivery, multi-cargo constructs, and increasingly complex modalities, the demands on characterization and analytical development have never been greater.
Traditional approaches are no longer sufficient to define product quality, understand structure-function relationships, or meet evolving regulatory expectations.
The 4th LNP Characterization & Analytical Development Summit is the only dedicated forum focused exclusively on solving the analytical and characterization challenges shaping the future of LNP-enabled medicines.
Join analytical development, characterization, formulation, and CMC leaders from across pharma and biotech to uncover the latest advances in predictive CQAs, structural characterization, targeted LNP analytics, multi-attribute methods, and strategies for complex payload systems. Through technical case studies, interactive discussions, poster presentations, and high-value networking, gain practical insight into how the industry is accelerating development while reducing risk.
As innovation in RNA medicines continues to outpace analytical standards, this is the critical meeting point to benchmark approaches, shape future best practice, and stay ahead of the next generation of LNP development.
Comprehensive sharing of cutting-edge methodologies for LNP characterization, including physicochemical techniques, potency assays, and in vitro–in vivo correlation, among others.
Tong Liu, Senior Principal Scientist
U.S Pharmacopeia
I appreciate very much the Hanson Wade conference series on LNP characterization. It brings together hands-on experts from different sides and allows in-debth exchange on a scientific level.
Heinrich Haas, Chief Technology Officer
NeoVac
Great small meeting that allowed for meaningful connections with everyone. Well-designed and engaging. Definitely will attend again!
Boguslaw Nocek, Senior Director
Eli Lilly & Co
Explore the Full Event Guide
- Get the complete event agenda, speaker faculty, and session highlights in one place
- Explore the latest topics shaping the future of LNP characterization and analytical development
- Preview key sessions covering predictive CQAs, targeted LNPs, multi-cargo systems, and advanced analytics
- Discover networking, poster presentation, and collaboration opportunities available onsite
- Share with colleagues and align your team on the sessions and insights not to miss
The 2025 Industry-Leading Speakers:
Attending Companies Include
Explore Related Events
Explore the Agenda
Discover the latest advances in LNP characterization and analytical development through expert-led presentations, interactive discussions, and technical case studies.
Partner With Us
Position your brand alongside industry leaders and connect directly with decision-makers advancing next-generation RNA and LNP therapeutics.
Join Industry Leaders
Connect with analytical, characterization, formulation, and CMC experts to exchange insights and build valuable partnerships across the LNP community.